Home 24-Hour Urine and Clearance Tests 24-Hour Urine 5-HIAA Test: Carcinoid Syndrome, Serotonin Metabolism, and High Levels

24-Hour Urine 5-HIAA Test: Carcinoid Syndrome, Serotonin Metabolism, and High Levels

By
Vita Library
-
2
Learn what a 24-hour urine 5-HIAA test measures, why high levels can suggest carcinoid syndrome, how to prepare, and what abnormal results may mean.

A 24-hour urine 5-HIAA test measures how much 5-hydroxyindoleacetic acid is excreted in urine over a full day. 5-HIAA is the main breakdown product of serotonin, so the test can help detect excess serotonin production from certain neuroendocrine tumors, especially when carcinoid syndrome is suspected. It is not a general cancer screening test, and one abnormal result does not identify a tumor by itself. Diet, medicines, supplements, kidney function, and collection errors can change the result. That is why preparation and a complete 24-hour collection matter as much as the number on the report. Doctors usually interpret 5-HIAA alongside symptoms, imaging, and other biochemical tests. Markedly high values are more concerning than small elevations, but the laboratory’s own reference interval should guide interpretation because methods and units differ.

  • The test measures serotonin breakdown: 5-HIAA is the major urinary metabolite of serotonin and is most useful when serotonin-secreting neuroendocrine tumors are suspected.
  • High results need context: A clearly elevated 24-hour value can support carcinoid syndrome, but foods, medicines, supplements, and collection problems can cause misleading results.
  • Preparation is test-specific: Many laboratories ask patients to avoid serotonin- or tryptophan-rich foods and certain interfering drugs for a defined period before and during collection.
  • Normal does not always exclude disease: Some neuroendocrine tumors do not produce much serotonin, and kidney impairment or intermittent secretion can affect urinary levels.
  • Very high 5-HIAA can matter beyond diagnosis: In confirmed carcinoid syndrome, sustained marked elevations may help estimate disease activity and the risk of complications such as carcinoid heart disease.

Table of Contents

What the 24-hour urine 5-HIAA test measures

The 24-hour urine 5-HIAA test measures the total amount of 5-HIAA eliminated in urine during one complete day. Serotonin is made from the amino acid tryptophan. After serotonin is used or released, the body breaks much of it down to 5-HIAA, which is then cleared mainly through the kidneys.

That pathway explains why the test is useful in neuroendocrine disease. Some neuroendocrine tumors, especially tumors arising from the midgut, can produce large amounts of serotonin. When enough serotonin or related substances reach the systemic circulation, a person may develop carcinoid syndrome. Common features include episodic flushing, frequent watery diarrhea, abdominal cramping, wheezing, and, in some people, damage to right-sided heart valves.

A 24-hour collection smooths out short-term variation. Serotonin production and urine concentration can change during the day, so a single urine sample may not reflect total daily output as reliably. The result is usually reported as an amount per 24 hours, such as milligrams per day, micrograms per day, or micromoles per day.

The test is different from a general urine serotonin measurement. It also differs from the 24-hour urine metanephrines test, which evaluates metabolites of catecholamines when pheochromocytoma or paraganglioma is suspected. The choice of test depends on the hormone pattern expected from the tumor being considered.

No single 5-HIAA value should be interpreted without its laboratory reference range. Assays, units, collection preservatives, and reporting conventions vary. The clinical question also matters: a borderline result during an initial workup carries different meaning from a persistently high result in someone with a confirmed serotonin-secreting tumor.

The source of serotonin also matters. Platelets store serotonin, but urinary 5-HIAA reflects metabolism across the body rather than a direct count of tumor cells. A large tumor burden can produce only a modest marker level if the tumor is not strongly serotonin-secreting, while a smaller functioning tumor can produce a clear biochemical signal. This is why imaging burden and 5-HIAA do not always rise or fall in parallel.

Why the test is ordered

Doctors most often order 24-hour urine 5-HIAA when symptoms raise concern for carcinoid syndrome or when a known neuroendocrine tumor needs biochemical assessment. The test is especially relevant when symptoms suggest recurrent serotonin release rather than a single isolated episode.

Flushing and diarrhea are common symptoms with many possible causes. Menopause, medications, alcohol, food reactions, mast-cell disorders, thyroid disease, infection, inflammatory bowel conditions, and anxiety-related autonomic symptoms can overlap with carcinoid syndrome. For that reason, 5-HIAA is most useful when the overall pattern makes a serotonin-secreting tumor plausible.

The test may also be ordered after imaging shows a mass that could be neuroendocrine in origin. In that setting, biochemical results can help characterize whether the tumor is functioning, meaning it actively releases a measurable hormone or metabolite.

Once a serotonin-producing neuroendocrine tumor is diagnosed, repeated 5-HIAA testing may help with follow-up. Trends can provide information about biochemical activity, although treatment decisions should not be based on the urine value alone. Imaging, symptoms, tumor burden, liver involvement, other biomarkers, and treatment response all contribute to the overall picture.

Carcinoid heart disease is another reason 5-HIAA can matter. Long-term exposure to high levels of serotonin and related mediators can contribute to fibrotic changes in heart valves. In people with established carcinoid syndrome, a markedly elevated 5-HIAA level can increase concern for this complication and may support closer cardiac assessment. It does not replace echocardiography or clinical evaluation.

A 5-HIAA test is usually not appropriate as a population screening test in people without suggestive symptoms or findings. Neuroendocrine tumors are uncommon, and low-pretest-probability testing increases the chance that a mildly abnormal result reflects interference rather than disease.

How to prepare and collect the urine

Accurate preparation is essential because several foods and drugs can alter serotonin metabolism or interfere with measurement. Instructions vary by laboratory, so the collection kit’s directions should take priority over generic advice.

Many laboratories ask patients to avoid foods rich in serotonin, tryptophan, or related compounds for about 2 to 3 days before collection and throughout the 24-hour collection. Commonly restricted items may include bananas, plantains, pineapple, kiwi, plums, avocados, tomatoes, eggplant, walnuts, and some other nuts. The exact list differs because assay methods differ.

Medicines and supplements can also affect results. Examples may include acetaminophen, certain antidepressants, cough or cold medicines, stimulants, and products containing tryptophan or serotonin-related compounds. However, do not stop a prescription drug solely to prepare for the test. The prescribing clinician or laboratory should decide whether a medication should be continued, paused, or simply documented.

The collection itself follows the standard timed-urine method. A typical process is:

  1. Choose the instructed start time, often in the morning.
  2. Urinate into the toilet at the start time and record that time; this first void is discarded.
  3. Collect every urine sample after that for the next 24 hours, including overnight samples.
  4. At exactly the same time the next day, urinate one final time and add that sample to the container.
  5. Keep the specimen refrigerated or otherwise stored exactly as instructed. Some containers include an acid preservative and require extra handling precautions.

A missed sample can make the result falsely low. Collecting beyond 24 hours can make the total falsely high. If a void is missed, the safest approach is usually to contact the laboratory and ask whether the collection must be restarted. The broader timed urine collection process explains why exact start and stop times matter.

Hydration should generally stay close to usual unless the care team gives different instructions. Deliberately drinking much more or much less than normal can change urine volume and may complicate interpretation. The laboratory may also use urine creatinine or total volume as clues to whether the collection was plausible, but neither measure proves completeness by itself.

Normal and high 5-HIAA results

A normal 24-hour urine 5-HIAA result means the measured amount falls within that laboratory’s reference interval. There is no universal cutoff that applies to every laboratory because assay methods and units differ. Many laboratories report a low-single-digit to low-teens milligram-per-day upper limit, but the number printed on the actual report should be used.

A result above the upper reference limit means more 5-HIAA was excreted than expected. The degree of elevation matters. A small rise may reflect diet, medication, stress on the collection process, or another non-tumor factor. A persistent and substantial rise, particularly in a person with compatible symptoms or known neuroendocrine disease, is more suggestive of clinically important serotonin overproduction.

Doctors often think about results in relation to the laboratory’s upper limit of normal rather than relying only on an absolute number. For example, a value several times above the upper limit is generally more concerning than a result only slightly above it. Even then, the test does not identify the tumor’s location, size, or stage.

In established carcinoid syndrome, very high urinary 5-HIAA can have prognostic relevance. Some neuroendocrine-tumor guidance uses levels above about 300 micromoles per 24 hours, which is roughly 57 mg per 24 hours, as one marker associated with increased risk of carcinoid heart disease. This is not a universal diagnostic cutoff for carcinoid syndrome. It is a disease-specific risk marker used in the broader clinical setting of confirmed or strongly suspected neuroendocrine disease.

A normal result does not rule out every neuroendocrine tumor. Some tumors do not produce serotonin, produce other hormones instead, or secrete intermittently. Foregut and hindgut neuroendocrine tumors may have different biochemical patterns. If suspicion remains high, clinicians may use other biochemical tests and imaging rather than relying on one normal urine collection.

False-high and false-low results

The most common reason to repeat a mildly abnormal 5-HIAA test is concern about interference or collection quality. Understanding these factors can prevent an unnecessary diagnostic cascade.

Food interference is a well-known cause of false elevation. Serotonin-rich foods or foods that affect tryptophan metabolism can temporarily raise urinary 5-HIAA. The effect is why laboratories provide dietary restriction lists. A patient who accidentally eats a restricted food should tell the care team rather than assuming the result is valid.

Medicines and supplements can raise or lower measured values through several mechanisms. Some alter serotonin production or metabolism; others interfere with the analytic method. The relevant drugs depend on the assay. A complete medication list, including over-the-counter products and supplements, is therefore part of good test preparation.

Collection errors can move the result in either direction. Missing urine lowers the measured 24-hour total. Collecting for too long can increase it. Spilling urine, failing to include the final void, using the wrong container, or failing to follow storage instructions can also reduce reliability. A 24-hour urine creatinine measurement may sometimes provide a rough completeness check, but expected creatinine excretion varies with muscle mass, age, sex, diet, and body size.

Kidney function matters because 5-HIAA is excreted in urine. Reduced kidney clearance can make urinary measurements less straightforward and, in some settings, may contribute to unexpectedly low urinary excretion relative to circulating levels. If chronic kidney disease is present, clinicians may rely more heavily on the complete clinical picture and alternative testing strategies.

Timing and biologic variation also matter. Neuroendocrine tumors can release hormones unevenly. When results are near a decision threshold or do not fit the symptoms, repeating the collection may be reasonable. Some specialists use two consecutive 24-hour collections to reduce the effect of day-to-day variation, especially when precise biochemical assessment is important.

Not every true elevation means a neuroendocrine tumor. Certain gastrointestinal disorders, malabsorption states, and other uncommon conditions can affect serotonin metabolism. That is why a biochemical abnormality should lead to a structured evaluation rather than an immediate conclusion.

What happens after an abnormal result

The next step depends on how abnormal the result is and why the test was ordered. A small unexpected elevation often leads first to a review of diet, medicines, supplements, kidney function, and collection technique. If an obvious interference occurred, the clinician may repeat the test after proper preparation.

When the result is clearly elevated and symptoms fit carcinoid syndrome, further evaluation usually focuses on confirming the biochemical signal and locating its source. Imaging may include cross-sectional studies such as CT or MRI and, when appropriate, somatostatin-receptor imaging. The exact sequence depends on prior imaging, symptoms, tumor history, local expertise, and test availability.

Other laboratory tests may also be used. Some clinicians measure plasma 5-HIAA, chromogranin A, or additional hormone markers, but each has limitations. Chromogranin A, for example, can be affected by proton-pump inhibitors, kidney dysfunction, and other conditions. No single blood or urine marker should be treated as a stand-alone cancer diagnosis.

If carcinoid syndrome is confirmed, evaluation may include assessment for complications. Recurrent diarrhea can cause dehydration and electrolyte losses. Long-standing serotonin excess can contribute to carcinoid heart disease. Depending on the clinical setting, clinicians may use natriuretic peptides, electrocardiography, and echocardiography to assess cardiac involvement.

Urgent medical evaluation is appropriate for severe dehydration, fainting, chest pain, major shortness of breath, rapid worsening of swelling, or a severe prolonged flushing episode with breathing difficulty or marked blood-pressure changes. These symptoms are not specific to carcinoid syndrome, but they can signal complications that need immediate assessment.

Using 5-HIAA for follow-up and monitoring

For people with a known serotonin-secreting neuroendocrine tumor, the most useful information often comes from trends rather than a single number. Testing should ideally use the same laboratory method, similar preparation, and comparable collection conditions so that changes over time are easier to interpret.

A falling 5-HIAA level after treatment can support a biochemical response, especially when symptoms also improve. A rising level can suggest increased serotonin production, but it does not automatically prove tumor growth. Dietary interference, new medicines, kidney-function changes, and collection quality should be considered before concluding that the disease has progressed.

Treatments such as somatostatin analogues can reduce hormone release and improve flushing or diarrhea. Other therapies may target the tumor itself or the serotonin pathway. The biochemical response may not perfectly match the imaging response, which is another reason clinicians combine laboratory, symptom, and imaging data.

In people with persistently high serotonin exposure, clinicians may pay particular attention to the heart. Carcinoid heart disease can develop even when gastrointestinal symptoms seem stable. Monitoring plans vary, but sustained high 5-HIAA, new shortness of breath, ankle swelling, reduced exercise tolerance, or a heart murmur may prompt echocardiography or more frequent cardiac review.

Patients can make follow-up testing more useful by using the same preparation routine each time, recording medication changes, noting major diet deviations, and collecting the full 24 hours accurately. A result that changes dramatically from the prior value should be checked against those practical details before it is treated as a true biologic change.

The key point is that 24-hour urine 5-HIAA is a targeted biochemical tool. It is strongest when it answers a specific clinical question, is collected correctly, and is interpreted alongside symptoms and imaging. A high value can be an important clue, but the diagnosis and long-term management of neuroendocrine tumors require more than one urine number.

References

Disclaimer

This article is for general educational purposes and does not diagnose carcinoid syndrome or a neuroendocrine tumor. A 24-hour urine 5-HIAA result should be interpreted by a qualified clinician using the laboratory’s reference range, your symptoms, medicines, kidney function, and other tests. Do not stop prescription medicines for test preparation unless the prescribing clinician or laboratory specifically tells you to do so.

RELATED ARTICLESMORE FROM AUTHOR